Skip to content
VTRSViatris

What Is VTRS Fair Value?

Viatris (VTRS) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Viatris (VTRS) has a composite fair value estimate of $30.89 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $16.68, suggesting the stock is undervalued by 85.2%.

Data as of July 16, 2026 (today)

Composite Fair Value

Undervalued4 of 4 models

$30.89

vs. current price of $16.68(+85.2%)

Undervalued$30.89Overvalued
$16.68

How Is VTRS Fair Value Calculated?

Four independent models estimate what VTRS is worth. Each uses different inputs and assumptions. The composite blends them by weight.

VTRS Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$41.26

+147.4%

Undervalued

Inputs used

FCF: 2.2BGrowth: 6.5%Discount: 7%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$7.96

-52.3%

Overvalued

Inputs used

Dividend: $0.48/yrReq. Return: 9%Growth: 3.2%

VTRS Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$26.34

+57.9%

Undervalued

Inputs used

EPS: $2.45Book Value: $12.59

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$24.50

+46.9%

Undervalued

Inputs used

EPS: $2.45Growth: 6.5%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$41.26Undervalued

Current price $16.68 is 147.4% below this estimate

CheapFair ValueExpensive
6.5%
0.0%30.0%
7.1%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.38B$2.23B
Year 2$2.54B$2.21B
Year 3$2.70B$2.20B
Year 4$2.88B$2.19B
Year 5$3.06B$2.17B
Year 6$3.26B$2.16B
Year 7$3.47B$2.15B
Year 8$3.69B$2.14B
Year 9$3.93B$2.12B
Year 10$4.19B$2.11B
Terminal Value$93.41B$47.07B

What Are VTRS's Key Financial Metrics?

Earnings & Growth

Current Price

$16.68

EPS (TTM)

-$0.31

Forward P/E

6.3

Profit Margin

-2.0%

Cash & Balance Sheet

Free Cash Flow

2.2B

EBITDA

4.1B

Book Value

$12.59

Total Debt

14.6B

What Do Analysts Say About VTRS?

Low

$12.00

Average

$17.81

High

$23.00

Upside

+6.8%

Current $16.68Avg Target $17.81Buy8 analysts

VTRS Fair Value FAQ

What is the fair value of VTRS?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), VTRS's estimated fair value is $30.89. The stock is currently trading at $16.68, which makes it undervalued by our analysis.

How is VTRS's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is VTRS overvalued or undervalued?

Based on our analysis, VTRS is undervalued. The current price of $16.68 is 85.2% below our estimated fair value of $30.89.

What do Wall Street analysts say about VTRS?

8 analysts cover Viatris with a consensus rating of "Buy." The average price target is $17.81, ranging from $12.00 to $23.00. This implies 6.8% upside from the current price.